BioFortis said this week that the Catholic Health Initiatives’ Institutes for Research and Innovation’s Center for Translational Research will use its Labmatrix software for workflow-driven protocols, specimen biobanking, next generation diagnostics, biomarker discovery, and translational research aimed at advancing the center’s personalized medicine research efforts.
BioFortis’ Labmatrix is a web-based software that lets users manage and integrate clinical, specimen, and molecular assay datasets and interface the data with other systems such as electronic medical records, genomic or proteomic databases, and laboratory information management systems.
BioFortis said that once the software is deployed, the center’s physicians and scientists can “explore and ask complex questions about the collected data,” which is expected to lead to “faster formulation and better utilization” of clinical and molecular assay data and ultimately lead to better treatment options for patients.
In addition, the partners plan to integrate the software with in-network hospitals’ electronic medical records systems.
Jeff Otto, CTR’s national director, said that Labmatrix will allow “CTR and its partners to trust the answers that flow from our research while protecting the privacy of our specimen donors.”
CTR is a clinical research, development and molecular diagnostics laboratory that supports the development of personalized medicine-centered research in the 72 hospitals that make up CHI's community-based healthcare system.